To assess the specificity of the α-synuclein-dependent ITPKB increase, we used SH-SY5Y neuroblastoma cells, in which LRRK2 or its most widespread mutant (G2019S) were expressed. The gene discussed is LRRK2; the disease is neuroblastoma.